Skip to content

Clinical application study of acupuncture combined with soft hand rehabilitation robot in the treatment of spasms after stroke

Clinical application study of acupuncture combined with soft hand rehabilitation robot in the treatment of spasms after stroke

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084258
Enrollment
Unknown
Registered
2024-05-13
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

experimental group:Acupuncture treatment, soft hand rehabilitation robot assisted rapid traction,conventional rehabilitation treatment

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? The diagnosis meets the criteria of the 4th National Conference on Cerebrovascular Diseases in 1995. The first diagnosis is an initial stroke (cerebral infarction or cerebral hemorrhage), confirmed by CT or MR Stable vital signs; Stroke lasting at least 2 weeks, with no history of traumatic brain injury, no history of brain parenchyma or central nervous system involvement such as encephalitis or tuberculous meningitis; ? Clear consciousness, possessing certain cognitive abilities, able to understand the requirements and commands proposed by the tester; ? For patients with finger flexor spasm, the Modified Ashworth Scale (MAS) meets the criteria of 0<MAS = 3; ? Age range from 18 to 80 years old.

Exclusion criteria

Exclusion criteria: ? Patients who meet the inclusion criteria but have not signed an informed consent form; ? Accompanied by other peripheral or central nervous system disorders; ? Accompanied by inflammatory symptoms, pathological changes, or deformities in the upper limbs; ? Accompanied by severe visual impairment; ? Patients with MAS>3 or severely restricted joint range of motion; ? Individuals with severe infections or comorbidities (heart, lung, liver, kidney) who use spasmodic drugs and have received botulinum toxin treatment in the past three months.

Design outcomes

Primary

MeasureTime frame
modified Ashworth Scale;

Secondary

MeasureTime frame
Fugl-Meyer assessment;MBI;EEG;

Countries

China

Contacts

Public ContactQuan Xu

Beijing Tsinghua Changgung Hospital

xuquanspecial@163.com+86 134 8871 6153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026